Research and Development

The Research and Development team at Alzprotect focuses on the discovery and advancement of innovative bioactive molecules aimed at treating neurodegenerative diseases. Led by the CEO and Chief Scientific Officer, the team conducts extensive preclinical research, pharmacological studies, and toxicology assessments to evaluate the safety and efficacy of potential therapies, driving the company's mission to improve patient outcomes.